Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03864068 · ClinicalTrials.gov registry record · Phase 2
Inositol Supplementation to Treat PCOS (INSUPP-PCOS)
A Phase 2 study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 154
- Enrollment target
NCT03864068 is a Phase 2 study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 154 participants.
The verdict
NCT03864068, a Phase 2 study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 154 participants
- Enrollment target
Study Summary
To determine if Inositol, a dietary supplement, will improve ovarian and adrenal androgen excess in women with Polycystic Ovarian Syndrome(PCOS).
Interventions
- OTHER Placebo
- DRUG Inositol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2020-01-24 |
| Est. Completion | 2025-12-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03864068
The ClinicalTrials.gov registry entry for NCT03864068 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03864068 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03864068 about?
NCT03864068 is a clinical study titled "Inositol Supplementation to Treat PCOS (INSUPP-PCOS)". To determine if Inositol, a dietary supplement, will improve ovarian and adrenal androgen excess in women with Polycystic Ovarian Syndrome(PCOS).
What is the current status of trial NCT03864068?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 154 participants. The study started on 2020-01-24. Estimated completion is 2025-12-10.
What interventions are being tested in trial NCT03864068?
The interventions under investigation include: Placebo (OTHER), Inositol (DRUG).
Who is sponsoring clinical trial NCT03864068?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.